Revalgin Pills, # 100

Revalgin tab.

No. 100

Name ENG

REVALGIN

Clinical and pharmacological group

Spasmodic analgesic

ATX code

Metamizole sodium in combination with other drugs (excluding psycholeptics

Dosage

500mg + 5mg + 100mcg

Structure

1 tablet contains: metamizole 500 mg, fenpiverinium bromide 0.1 mg, pitofenone hydrochloride 5 mg.

Indications

Pain syndrome with spasms of smooth muscles of internal organs (renal and biliary colic, intestinal spasms, dysmenorrhea, etc.), headache, migraine, joint pain, neuralgia, sciatica and myalgia (short-term symptomatic treatment), pain after surgical and diagnostic interventions ( adjuvant), increased body temperature for colds and infectious and inflammatory diseases (if necessary)

Contraindications

Hypersensitivity, severe impaired liver or kidney function, genetic deficiency of glucose-6-phosphate dehydrogenase, tachyarrhythmia, angle-closure glaucoma, prostatic hypertrophy with a tendency to urinary retention, gastrointestinal obstruction, megacolon, blood system diseases, collaptoid and recent conditions, I trimester 6 weeks of pregnancy, breastfeeding, up to 5 years of age (tablets), up to 3 months / body weight less than 5 kg (solution for injection i / m injection) and up to 3-5 months / body weight 5-8 kg (solution for injection i / in the introduction).

Storage conditions and periods

In a dry place, at a temperature not exceeding 25 degrees.

Expiration date: 3 years

INN / Active ingredient

fenpiverinium bromide + pitofenone + metamizole sodium

Specifications

Category

Pain relievers

,

Migraine

Scope of the drug

General

Release form

Tablet

Manufacturer country

India

Package quantity, pcs

one hundred

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Shreya

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Cell-free contoured packaging (strip)

Type of consumer packaging

Pack of cardboard

Dosage form

Pills

Packaging

Box

The target audience

Adult

Expiration date in days

1095

Package weight, g

110

Mode of application

:

Revalgin in the form of tablets for oral administration is prescribed:

Adults and adolescents over 15 years old 1-2 tablets 2-3 times / day.

The maximum daily dose is 6 tablets.

Duration of admission is no more than 5 days.

Children aged 6-8 years are prescribed 1/2 tablet.

Children aged 9-12 years - 3/4 tablets.

Children aged 13-15 years - 1 tablet.

Frequency rate of admission - 2-3 times / day.

The tablets should be taken orally, preferably after meals.

Pharmaco-therapeutic group

:

Combined analgesic (non-narcotic analgesic + antispasmodic)

Anatomical and therapeutic characteristics

:

N02BB52 Metamizole sodium, in combination with other drugs (excluding psychotropic drugs)

Dosage (volume) of the substance in the preparation

:

1 tab.

metamizole 500 mg, pitofenone hydrochloride 5 mg, fenpiverinium bromide 100 μg